News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,524 Results
Type
Article (41716)
Company Profile (473)
Press Release (661335)
Section
Business (208444)
Career Advice (2010)
Deals (35953)
Drug Delivery (97)
Drug Development (83361)
Employer Resources (169)
FDA (16343)
Job Trends (15051)
News (352209)
Policy (33000)
Tag
Academia (2619)
Alliances (50707)
Alzheimer's disease (1302)
Approvals (16282)
Artificial intelligence (154)
Bankruptcy (361)
Best Places to Work (11784)
Biotechnology (355)
Breast cancer (193)
Cancer (1405)
Cardiovascular disease (117)
Career advice (1677)
Cell therapy (301)
Clinical research (66462)
Collaboration (508)
Compensation (263)
COVID-19 (2601)
C-suite (114)
Data (1413)
Diabetes (176)
Diagnostics (6229)
Earnings (86119)
Employer resources (147)
Events (113485)
Executive appointments (402)
FDA (17027)
Funding (447)
Gene therapy (213)
GLP-1 (633)
Government (4418)
Healthcare (19023)
Infectious disease (2693)
Inflammatory bowel disease (118)
Interviews (309)
IPO (16618)
Job creations (3696)
Job search strategy (1430)
Layoffs (445)
Legal (7942)
Lung cancer (202)
Lymphoma (100)
Manufacturing (214)
Medical device (13359)
Medtech (13364)
Mergers & acquisitions (19486)
Metabolic disorders (478)
Neuroscience (1642)
NextGen Class of 2024 (6738)
Non-profit (4538)
Northern California (1716)
Obesity (273)
Opinion (202)
Patents (118)
People (57821)
Phase I (20854)
Phase II (29337)
Phase III (21690)
Pipeline (523)
Postmarket research (2598)
Preclinical (8937)
Radiopharmaceuticals (252)
Rare diseases (278)
Real estate (5998)
Regulatory (22111)
Research institute (2405)
Resumes & cover letters (351)
Southern California (1490)
Startups (3747)
United States (15605)
Vaccines (580)
Weight loss (198)
Date
Today (3)
Last 7 days (599)
Last 30 days (2416)
Last 365 days (36269)
2024 (36088)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54925)
2019 (47421)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38397)
2014 (32185)
2013 (27109)
2012 (29222)
2011 (29864)
2010 (27994)
Location
Africa (731)
Arizona (203)
Asia (38666)
Australia (6432)
California (3917)
Canada (1458)
China (310)
Colorado (175)
Connecticut (187)
Europe (84334)
Florida (537)
Georgia (135)
Illinois (398)
Indiana (227)
Maryland (642)
Massachusetts (3093)
Michigan (174)
Minnesota (296)
New Jersey (1124)
New York (1098)
North Carolina (802)
Northern California (1716)
Ohio (148)
Pennsylvania (934)
South America (1105)
Southern California (1490)
Texas (563)
Utah (110)
Washington State (414)
703,524 Results for "amicus therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
November 6, 2024
·
19 min read
Press Releases
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
November 4, 2024
·
1 min read
Pharm Country
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 11, 2024, at 4:00 p.m. E.T.
June 5, 2024
·
1 min read
Business
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
Amicus Therapeutics, a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, announced financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
16 min read
Press Releases
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
October 28, 2024
·
1 min read
Pharm Country
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
Amicus Therapeutics announced that management will participate in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024, at 1:40 p.m. P.T.
May 8, 2024
·
1 min read
Press Releases
Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
October 4, 2024
·
1 min read
Pharm Country
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
Amicus Therapeutics announced that management will participate in upcoming presentations at the following investor conferences in March.
March 1, 2024
·
1 min read
Press Releases
Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium
September 3, 2024
·
2 min read
Pharm Country
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
Amicus Therapeutics, a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, issued its fourth annual Environmental, Social, and Governance report.
March 20, 2024
·
4 min read
1 of 70,353
Next
